A phase IIa study of docetaxel (CriPec®) for solid tumors

Trial Profile

A phase IIa study of docetaxel (CriPec®) for solid tumors

Phase of Trial: Phase II

Latest Information Update: 25 Jan 2017

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2017 New trial record
    • 19 Jan 2017 According to a Cristal Therapeutics media release, this study is expected to initiate later in the year 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top